Equitable Holdings’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $350K | Sell |
2,168
-43
| -2% | -$6.94K | ﹤0.01% | 1137 |
|
2025
Q1 | $376K | Sell |
2,211
-7
| -0.3% | -$1.19K | ﹤0.01% | 1017 |
|
2024
Q4 | $369K | Sell |
2,218
-35
| -2% | -$5.82K | ﹤0.01% | 968 |
|
2024
Q3 | $387K | Sell |
2,253
-40
| -2% | -$6.88K | ﹤0.01% | 945 |
|
2024
Q2 | $353K | Sell |
2,293
-185
| -7% | -$28.5K | ﹤0.01% | 945 |
|
2024
Q1 | $381K | Sell |
2,478
-323
| -12% | -$49.7K | ﹤0.01% | 898 |
|
2023
Q4 | $443K | Sell |
2,801
-750
| -21% | -$119K | 0.01% | 809 |
|
2023
Q3 | $520K | Sell |
3,551
-231
| -6% | -$33.8K | 0.01% | 707 |
|
2023
Q2 | $579K | Buy |
3,782
+273
| +8% | +$41.8K | 0.01% | 659 |
|
2023
Q1 | $544K | Sell |
3,509
-1,136
| -24% | -$176K | 0.01% | 629 |
|
2022
Q4 | $716K | Buy |
4,645
+423
| +10% | +$65.2K | 0.01% | 522 |
|
2022
Q3 | $557K | Sell |
4,222
-40
| -0.9% | -$5.28K | 0.01% | 539 |
|
2022
Q2 | $578K | Buy |
4,262
+105
| +3% | +$14.2K | 0.01% | 529 |
|
2022
Q1 | $620K | Buy |
4,157
+1,295
| +45% | +$193K | 0.01% | 526 |
|
2021
Q4 | $464K | Buy |
2,862
+975
| +52% | +$158K | 0.01% | 583 |
|
2021
Q3 | $313K | Buy |
1,887
+507
| +37% | +$84.1K | 0.01% | 661 |
|
2021
Q2 | $238K | Hold |
1,380
| – | – | ﹤0.01% | 732 |
|
2021
Q1 | $221K | Buy |
1,380
+20
| +1% | +$3.2K | ﹤0.01% | 699 |
|
2020
Q4 | $228K | Sell |
1,360
-4
| -0.3% | -$671 | 0.01% | 623 |
|
2020
Q3 | $215K | Sell |
1,364
-16
| -1% | -$2.52K | 0.01% | 579 |
|
2020
Q2 | $232K | Buy |
+1,380
| New | +$232K | 0.01% | 559 |
|